Mon, August 21, 2023
Fri, August 18, 2023
Thu, August 17, 2023
Wed, August 16, 2023
Tue, August 15, 2023

Anupam Rama Maintained (BBIO) at Buy with Decreased Target to $38 on, Aug 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-38-on-aug-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $42 to $38 on, Aug 17th, 2023.

Anupam has made no other calls on BBIO in the last 4 months.



There are 5 other peers that have a rating on BBIO. Out of the 5 peers that are also analyzing BBIO, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $33 on, Tuesday, July 18th, 2023


These are the ratings of the 4 analyists that currently disagree with Anupam


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $60 on, Monday, August 14th, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $50 on, Tuesday, July 18th, 2023
  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $46 on, Tuesday, July 18th, 2023
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $40 on, Wednesday, April 19th, 2023

Publication Contributing Sources